Resistance to Ibritumomab in Lymphoma / edited by Makoto Hosono, Jean-François Chatal.
Contributor(s): SpringerLink (Online service)
| Hosono, Makoto., editor literario | Chatal, Jean-François., editor literario
Series: (Resistance to Targeted Anti-Cancer Therapeutics, 2196-5501 ; 18); (Biomedical and Life Sciences (Springer-11642)).Publisher: Cham, Switzerland : Springer International Publishing, 2018Description: 1 recurso en línea (XIII, 158 páginas 18 ilustraciones,14 ilustraciones a color).ISBN: 9783319782386.Subject: CáncerOnline resources: Acceso a este recurso digital (usuarios Universidad Europea de Madrid)
| Item type | Current library | Collection | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | RC261 (Browse shelf(Opens below)) | Acceso electrónico | eBook.26112213 |
Browsing Madrid Digital shelves, Shelving location: Acceso Electrónico (UEM) Close shelf browser (Hides shelf browser)
| RC256 .L636 2018 EB Locoregional Tumor Therapy | RC257 .R3 2019 EB Nuclear Medicine in Oncology Molecular Imaging and Target Therapy | RC257 .T374 2015 EB Targeted Therapies for Solid Tumors : A Handbook for Moving Toward New Frontiers in Cancer Treatment | RC261 Resistance to Ibritumomab in Lymphoma | RC261 Immunotherapy | RC261 2005 EB Cancer, principles & practice of oncology | RC261 2009 EB Devita, Hellman, and Rosenberg's cancer : principles & practice of oncology |
Clinical Use and Efficacy of Ibritumomab in B-cell Lymphoma -- Biology and Pathology of B-cell lymphoma -- Resistance to Y-90 Ibritumomab Tiuxetan Therapy -- Features of Ibritumomab as Radionuclide Therapy -- Radiological Evaluation of Response and Resistance of Ibritumomab -- Characteristics of Ibritumomab as Radionuclide Therapy Agent -- Resistance and Heterogeneity of Intratumoral Antibody Distribution -- Radiation Dosimetry in Ibritumomab Therapy -- Combining RAIT and immune-based therapies to overcome resistance in cancer? -- Prospects for enhancing efficacy of radioimmunotherapy -- Index.
This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.
There are no comments on this title.